0001209191-20-000814.txt : 20200103
0001209191-20-000814.hdr.sgml : 20200103
20200103160945
ACCESSION NUMBER: 0001209191-20-000814
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 20505352
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001069308
Acer Therapeutics Inc.
ACER
0001451805
Amello Jason
C/O ACER THERAPEUTICS INC.
ONE GATEWAY CTR. STE. 351
NEWTON
MA
02458
1
0
0
0
Stock Option (right to buy)
3.79
2020-01-02
4
A
0
9000
0.00
A
2030-01-02
Common Stock
9000
9000
D
The option vests and becomes exercisable in full on January 2, 2021.
/s/ Harry Palmin, Attorney-in-Fact
2020-01-03